MedPath

"Natural History" Study of Choroideremia

Terminated
Conditions
Choroideremia
Interventions
Other: Observation
Registration Number
NCT02994368
Lead Sponsor
4D Molecular Therapeutics
Brief Summary

The purpose of this study is to understand the rate of progression of all stages of choroideremia using a variety of assessments performed in the clinic including visual field measures, specialized photography of the eye and participant-reported visual problems

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Male
Target Recruitment
57
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Primary CohortObservationNo intervention
Expansion CohortObservationNo intervention
Primary Outcome Measures
NameTimeMethod
Rate of progression of disease4 years

A variety of psychophysical, anatomical and image-based endpoints

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (4)

Retina Foundation of the Southwest

🇺🇸

Dallas, Texas, United States

Baylor College of Medicine, Ophthalmology-Cullen Eye Center

🇺🇸

Houston, Texas, United States

University of Alberta

🇨🇦

Edmonton, Alberta, Canada

Moran Eye Center, University of Utah

🇺🇸

Salt Lake City, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath